Citation: | Bao Zhiye, Liu Hao. Diagnosis and treatment strategy of intestinal flora imbalance after liver transplantation[J]. ORGAN TRANSPLANTATION, 2022, 13(4): 469-474. doi: 10.3969/j.issn.1674-7445.2022.04.009 |
[1] |
KRISS M, VERNA EC, ROSEN HR, et al. Functional microbiomics in liver transplantation: identifying novel targets for improving allograft outcomes[J]. Transplantation, 2019, 103(4): 668-678. DOI: 10.1097/TP.0000000000002568.
|
[2] |
ANCONA G, ALAGNA L, LOMBARDI A, et al. The interplay between gut microbiota and the immune system in liver transplant recipients and its role in infections[J]. Infect Immun, 2021, 89(11): e0037621. DOI: 10.1128/IAI.00376-21.
|
[3] |
OH HS, MIN U, JANG H, et al. Proposal of a health gut microbiome index based on a Meta-analysis of Korean and global population datasets[J]. J Microbiol, 2022, 60(5): 533-549. DOI: 10.1007/s12275-022-1526-0.
|
[4] |
AHLAWAT S, ASHA, SHARMA KK. Gut-organ axis: a microbial outreach and networking[J]. Lett Appl Microbiol, 2021, 72(6): 636-668. DOI: 10.1111/lam.13333.
|
[5] |
YAN S, YIN XM. Gut microbiome in liver pathophysiology and cholestatic liver disease[J]. Liver Res, 2021, 5(3): 151-163. DOI: 10.1016/j.livres.2021.08.001.
|
[6] |
BAJAJ JS, KHORUTS A. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis[J]. J Hepatol, 2020, 72(5): 1003-1027. DOI: 10.1016/j.jhep.2020.01.017.
|
[7] |
PIROZZOLO I, LI Z, SEPULVEDA M, et al. Influence of the microbiome on solid organ transplant survival[J]. J Heart Lung Transplant, 2021, 40(8): 745-753. DOI: 10.1016/j.healun.2021.04.004.
|
[8] |
ZHENG D, LIWINSKI T, ELINAV E. Interaction between microbiota and immunity in health and disease[J]. Cell Res, 2020, 30(6): 492-506. DOI: 10.1038/s41422-020-0332-7.
|
[9] |
MONGODIN EF, SAXENA V, IYYATHURAI J, et al. Chronic rejection as a persisting phantom menace in organ transplantation: a new hope in the microbiota?[J]. Curr Opin Organ Transplant, 2021, 26(6): 567-581. DOI: 10.1097/MOT.0000000000000929.
|
[10] |
DERY KJ, KADONO K, HIRAO H, et al. Microbiota in organ transplantation: an immunological and therapeutic conundrum?[J]. Cell Immunol, 2020, 351: 104080. DOI: 10.1016/j.cellimm.2020.104080.
|
[11] |
FU PP, XIONG F, WU SG, et al. Effects of schyzocotyle acheilognathi (Yamaguti, 1934) infection on the intestinal microbiota, growth and immune reactions of grass carp (ctenopharyngodon idella)[J]. PLoS One, 2022, 17(4): e0266766. DOI: 10.1371/journal.pone.0266766.
|
[12] |
YANG XA, LV F, WANG R, et al. Potential role of intestinal microflora in disease progression among patients with different stages of hepatitis B[J]. Gut Pathog, 2020, 12: 50. DOI: 10.1186/s13099-020-00391-4.
|
[13] |
SOLÉ C, GUILLY S, DA SILVA K, et al. Alterations in gut microbiome in cirrhosis as assessed by quantitative metagenomics: relationship with acute-on-chronic liver failure and prognosis[J]. Gastroenterology, 2021, 160(1): 206-218. DOI: 10.1053/j.gastro.2020.08.054.
|
[14] |
BAJAJ JS, KAKIYAMA G, COX IJ, et al. Alterations in gut microbial function following liver transplant[J]. Liver Transpl, 2018, 24(6): 752-761. DOI: 10.1002/lt.25046.
|
[15] |
CHEN Y, GUO J, QIAN G, et al. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality[J]. J Gastroenterol Hepatol, 2015, 30(9): 1429-1437. DOI: 10.1111/jgh.12932.
|
[16] |
BAJAJ JS, HEUMAN DM, HYLEMON PB, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications[J]. J Hepatol, 2014, 60(5): 940-947. DOI: 10.1016/j.jhep.2013.12.019.
|
[17] |
GRĄT M, HOŁÓWKO W, WRONKA KM, et al. The relevance of intestinal dysbiosis in liver transplant candidates[J]. Transpl Infect Dis, 2015, 17(2): 174-184. DOI: 10.1111/tid.12352.
|
[18] |
CORNIDE-PETRONIO ME, ÁLVAREZ-MERCADO AI, JIMÉNEZ-CASTRO MB, et al. Current knowledge about the effect of nutritional status, supplemented nutrition diet, and gut microbiota on hepatic ischemia-reperfusion and regeneration in liver surgery[J]. Nutrients, 2020, 12(2): 284. DOI: 10.3390/nu12020284.
|
[19] |
OIKONOMOU T, PAPATHEODORIDIS GV, SAMARKOS M, et al. Clinical impact of microbiome in patients with decompensated cirrhosis[J]. World J Gastroenterol, 2018, 24(34): 3813-3820. DOI: 10.3748/wjg.v24.i34.3813.
|
[20] |
BAJAJ JS, IDILMAN R, MABUDIAN L, et al. Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort[J]. Hepatology, 2018, 68(1): 234-247. DOI: 10.1002/hep.29791.
|
[21] |
FILOS KS, KIRKILESIS I, SPILIOPOULOU I, et al. Bacterial translocation, endotoxaemia and apoptosis following Pringle manoeuvre in rats[J]. Injury, 2004, 35(1): 35-43. DOI: 10.1016/s0020-1383(03)00288-2.
|
[22] |
LA ROSA R, JOHANSEN HK, MOLIN S. Persistent bacterial infections, antibiotic treatment failure, and microbial adaptive evolution[J]. Antibiotics (Basel), 2022, 11(3): 419. DOI: 10.3390/antibiotics11030419.
|
[23] |
ZAZA G, DALLA GASSA A, FELIS G, et al. Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: comparison between an everolimus- and a standard tacrolimus-based regimen[J]. PLoS One, 2017, 12(5): e0178228. DOI: 10.1371/journal.pone.0178228.
|
[24] |
JARDOU M, PROVOST Q, BROSSIER C, et al. Alteration of the gut microbiome in mycophenolate-induced enteropathy: impacts on the profile of short-chain fatty acids in a mouse model[J]. BMC Pharmacol Toxicol, 2021, 22(1): 66. DOI: 10.1186/s40360-021-00536-4.
|
[25] |
TIAN X, YANG Z, LUO F, et al. Gut microbial balance and liver transplantation: alteration, management, and prediction[J]. Front Med, 2018, 12(2): 123-129. DOI: 10.1007/s11684-017-0563-2.
|
[26] |
XIE Y, LUO Z, LI Z, et al. Structural shifts of fecal microbial communities in rats with acute rejection after liver transplantation[J]. Microb Ecol, 2012, 64(2): 546-554. DOI: 10.1007/s00248-012-0030-1.
|
[27] |
JIANG JW, REN ZG, CUI GY, et al. Chronic bile duct hyperplasia is a chronic graft dysfunction following liver transplantation[J]. World J Gastroenterol, 2012, 18(10): 1038-1047. DOI: 10.3748/wjg.v18.i10.1038.
|
[28] |
ANNAVAJHALA MK, GOMEZ-SIMMONDS A, MACESIC N, et al. Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation[J]. Nat Commun, 2019, 10(1): 4715. DOI: 10.1038/s41467-019-12633-4.
|
[29] |
GUO Y, CRNKOVIC CM, WON KJ, et al. Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites[J]. Drug Metab Dispos, 2019, 47(3): 194-202. DOI: 10.1124/dmd.118.084772.
|
[30] |
ZHANG Z, LIU L, TANG H, et al. Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice[J]. Am J Transplant, 2018, 18(7): 1646-1656. DOI: 10.1111/ajt.14661.
|
[31] |
JIA J, TIAN X, JIANG J, et al. Structural shifts in the intestinal microbiota of rats treated with cyclosporine A after orthotropic liver transplantation[J]. Front Med, 2019, 13(4): 451-460. DOI: 10.1007/s11684-018-0675-3.
|
[32] |
LI R, XIE L, LI L, et al. The gut microbial metabolite, 3, 4-dihydroxyphenylpropionic acid, alleviates hepatic ischemia/reperfusion injury via mitigation of macrophage pro-inflammatory activity in mice[J]. Acta Pharm Sin B, 2022, 12(1): 182-196. DOI: 10.1016/j.apsb.2021.05.029.
|
[33] |
KATCHMAN E, MARQUEZ M, BAZERBACHI F, et al. A comparative study of the use of selective digestive decontamination prophylaxis in living-donor liver transplant recipients[J]. Transpl Infect Dis, 2014, 16(4): 539-547. DOI: 10.1111/tid.12235.
|
[34] |
SORBARA MT, DUBIN K, LITTMANN ER, et al. Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification[J]. J Exp Med, 2019, 216(1): 84-98. DOI: 10.1084/jem.20181639.
|
[35] |
ZHANG J, REN FG, LIU P, et al. Characteristics of fecal microbial communities in patients with non-anastomotic biliary strictures after liver transplantation[J]. World J Gastroenterol, 2017, 23(46): 8217-8226. DOI: 10.3748/wjg.v23.i46.8217.
|
[36] |
KAHN J, PREGARTNER G, SCHEMMER P. Effects of both pro- and synbiotics in liver surgery and transplantation with special focus on the gut-liver axis-a systematic review and Meta-analysis[J]. Nutrients, 2020, 12(8): 2461. DOI: 10.3390/nu12082461.
|
[37] |
KIM SG, BECATTINI S, MOODY TU, et al. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant enterococcus[J]. Nature, 2019, 572(7771): 665-669. DOI: 10.1038/s41586-019-1501-z.
|
[38] |
CHONG PP, KOH AY. The gut microbiota in transplant patients[J]. Blood Rev, 2020, 39: 100614. DOI: 10.1016/j.blre.2019.100614.
|
[39] |
BAJAJ JS, SHAMSADDINI A, FAGAN A, et al. Fecal microbiota transplant in cirrhosis reduces gut microbial antibiotic resistance genes: analysis of two trials[J]. Hepatol Commun, 2020, 5(2): 258-271. DOI: 10.1002/hep4.1639.
|
[40] |
MCDONALD LC, GERDING DN, JOHNSON S, et al. Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)[J]. Clin Infect Dis, 2018, 66(7): e1-e48. DOI: 10.1093/cid/cix1085.
|
[41] |
SCHLUGER A, ROSENBLATT R, KNOTTS R, et al. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients[J]. Transpl Infect Dis, 2019, 21(6): e13184. DOI: 10.1111/tid.13184.
|
[42] |
CHENG YW, PHELPS E, GANAPINI V, et al. Fecal microbiota transplantation for the treatment of recurrent and severe clostridium difficile infection in solid organ transplant recipients: a multicenter experience[J]. Am J Transplant, 2019, 19(2): 501-511. DOI: 10.1111/ajt.15058.
|
[43] |
QURAISHI MN, WIDLAK M, BHALA N, et al. Systematic review with Meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory clostridium difficile infection[J]. Aliment Pharmacol Ther, 2017, 46(5): 479-493. DOI: 10.1111/apt.14201.
|
[44] |
HALAWEISH HF, BOATMAN S, STALEY C. Encapsulated fecal microbiota transplantation: development, efficacy, and clinical application[J]. Front Cell Infect Microbiol, 2022, 12: 826114. DOI: 10.3389/fcimb.2022.826114.
|
[45] |
DEFILIPP Z, BLOOM PP, TORRES SOTO M, et al. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant[J]. N Engl J Med, 2019, 381(21): 2043-2050. DOI: 10.1056/NEJMoa1910437.
|